Phase 4 Haemophilia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are scheduled to have heart surgery
Who may not be able to join:
- People who have thrombocytopenia (a condition where the blood has a lower than normal number of platelets, which help with clotting)
- People who are currently taking oral blood-thinning medication (anticoagulants taken by mouth)
- People who are currently taking antiplatelet medications (drugs that help prevent blood clots by stopping platelets from sticking together)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Tae-Yop Kim, MD PhD, Konkuk University Medical Center
Phone: +82-10-8811-6942
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
treatment time
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.